Sweeney CJ - Search Results

1

Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.

Yip-Schneider MT, Sweeney CJ, Jung SH, Crowell PL, Marshall MS. Yip-Schneider MT, et al. Among authors: sweeney cj. J Pharmacol Exp Ther. 2001 Sep;298(3):976-85. J Pharmacol Exp Ther. 2001. PMID: 11504793

2

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.

Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, Sweeney CJ. Yip-Schneider MT, et al. Among authors: sweeney cj. Carcinogenesis. 2000 Feb;21(2):139-46. doi: 10.1093/carcin/21.2.139. Carcinogenesis. 2000. PMID: 10657949

3

Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.

Yip-Schneider MT, Lin A, Barnard D, Sweeney CJ, Marshall MS. Yip-Schneider MT, et al. Among authors: sweeney cj. Int J Oncol. 1999 Aug;15(2):271-9. doi: 10.3892/ijo.15.2.271. Int J Oncol. 1999. PMID: 10402237

4

A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer.

Sweeney CJ, Monaco FJ, Jung SH, Wasielewski MJ, Picus J, Ansari RH, Dugan WM, Einhorn LH. Sweeney CJ, et al. Ann Oncol. 2002 Mar;13(3):435-40. doi: 10.1093/annonc/mdf029. Ann Oncol. 2002. PMID: 11996476 Free article. Clinical Trial.

5

Suppression of NF-kappaB activity by parthenolide induces X-ray sensitivity through inhibition of split-dose repair in TP53 null prostate cancer cells.

Watson C, Miller DA, Chin-Sinex H, Losch A, Hughes W, Sweeney C, Mendonca MS. Watson C, et al. Radiat Res. 2009 Apr;171(4):389-96. doi: 10.1667/RR1394.1. Radiat Res. 2009. PMID: 19397439

6

Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system.

Zhang S, Zeng G, Kao C, Gardner T, Sweeney C, Yang NS, Eble JN, Cheng L. Zhang S, et al. Prostate. 2002 Sep 15;53(1):69-76. doi: 10.1002/pros.10132. Prostate. 2002. PMID: 12210482

7

Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair.

Mendonca MS, Chin-Sinex H, Gomez-Millan J, Datzman N, Hardacre M, Comerford K, Nakshatri H, Nye M, Benjamin L, Mehta S, Patino F, Sweeney C. Mendonca MS, et al. Radiat Res. 2007 Dec;168(6):689-97. doi: 10.1667/RR1128.1. Radiat Res. 2007. PMID: 18088190

8

Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma.

Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D, Johnson DH. Sweeney CJ, et al. Cancer. 2001 Nov 15;92(10):2639-47. doi: 10.1002/1097-0142(20011115)92:10<2639::aid-cncr1617>3.0.co;2-8. Cancer. 2001. PMID: 11745199 Clinical Trial.

9

The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

Sweeney CJ, Miller KD, Sissons SE, Nozaki S, Heilman DK, Shen J, Sledge GW Jr. Sweeney CJ, et al. Cancer Res. 2001 Apr 15;61(8):3369-72. Cancer Res. 2001. PMID: 11309294

10

Chemotherapy in non-small cell lung cancer.

Sweeney CJ, Sandler AB. Sweeney CJ, et al. Invest New Drugs. 2000 May;18(2):157-86. doi: 10.1023/a:1006330030333. Invest New Drugs. 2000. PMID: 10857995 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters